Sponsor pipeline

Rezolute clinical trial pipeline

Get alerts when Rezolute's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06881992 A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism Tumor Hyperinsulinism (Tumor HI) Recruiting 2026-09-28
NCT06208215 RZ358 Treatment for Congenital Hyperinsulinism Congenital Hyperinsulinism Active, Not Recruiting 2026-01-08

Disease areas by active trials

Pancreatic Cancer (1) · Sarcoma (1)

Get alerts when Rezolute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free